Moolec Science (MLEC) Stock Price, News & Analysis

Company Overview

Moolec Science SA, a science-based food ingredient company, focuses on developing real animal proteins in plants using molecular farming. It offers Chymosin SPC, a dairy ingredient; GLA SONOVA, a nutritional oil; POORK+, a plant-based, animal meat free ingredient with porcine proteins in soybeans; and BEEF+, a meat replacement product. It operates in the United States, Europe, and South America. The company was founded in 2020 and is based in Luxembourg.

Key Stats

• Today's Range: $7.00 to $7.61
• 50-Day Range: $5.60 to $9.30
• 52-Week Range: $5.30 to $11.80
• Volume: 1,729 shs
• Average Volume: 3,931 shs
• Market Capitalization: $29.46 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Moolec Science Stock Analysis - MarketRank™

Moolec Science scored higher than 7% of companies evaluated by MarketBeat, and ranked 139th out of 147 stocks in the consumer staples sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for Moolec Science.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Moolec Science is -35.17, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Moolec Science is -35.17, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Moolec Science has a P/B Ratio of 41.03. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

1.46% of the float of Moolec Science has been sold short.

Short Interest Ratio / Days to Cover

Moolec Science has a short interest ratio ("days to cover") of 2.2, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Moolec Science has recently decreased by 90.61%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Moolec Science does not currently pay a dividend.

Dividend Growth

Moolec Science does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

1.46% of the float of Moolec Science has been sold short.

Short Interest Ratio / Days to Cover

Moolec Science has a short interest ratio ("days to cover") of 2.2, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Moolec Science has recently decreased by 90.61%, indicating that investor sentiment is improving significantly.

News and Social Media

• Score: 0.0 / 5
• News Sentiment: 0.00

News Coverage This Week

MarketBeat has tracked 5 news articles for Moolec Science this week, compared to 0 articles on an average week.

Search Interest

Only 1 people have searched for MLEC on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.

Company Ownership

• Score: 0.8 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Moolec Science insiders have not sold or bought any company stock.

Percentage Held by Insiders

19.90% of the stock of Moolec Science is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

Only 0.07% of the stock of Moolec Science is held by institutions.

MLEC Stock Analysis - Frequently Asked Questions

How have MLEC shares performed this year?

Moolec Science's stock was trading at $8.00 on January 1st, 2025. Since then, MLEC shares have decreased by 7.7% and is now trading at $7.3850.
View the best growth stocks for 2025 here.

How were Moolec Science's earnings last quarter?

Moolec Science SA (NASDAQ:MLEC) issued its quarterly earnings results on Wednesday, April, 16th. The company reported ($0.60) EPS for the quarter, meeting analysts' consensus estimates of ($0.60). The company earned $2.64 million during the quarter, compared to the consensus estimate of $2.01 million. Moolec Science had a negative trailing twelve-month return on equity of 119.34% and a negative net margin of 140.32%.

When did Moolec Science's stock split?

Shares of Moolec Science reverse split before market open on Wednesday, May 14th 2025. The 1-10 reverse split was announced on Tuesday, April 29th 2025. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, May 13th 2025. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

How do I buy shares of Moolec Science?

Shares of MLEC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Moolec Science own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Moolec Science investors own include PayPal (PYPL), TriNet Group (TNET), Tesla (TSLA), ABM Industries (ABM), Adverum Biotechnologies (ADVM), APi Group (APG) and Avino Silver & Gold Mines (ASM).

Company Calendar

• Last Earnings: 4/16/2025
• Today: 6/06/2025
• Fiscal Year End: 6/30/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Consumer Staples
• Industry: Holding & other investment offices
• Sub-Industry: Trading
• Current Symbol: NASDAQ:MLEC
• CIK: 1937737
• Web: moolecscience.com
• Phone: 650-515-3930
• Fax: N/A
• Employees: 4
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): ($2.20)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$7.31 million
• Net Margins: -140.32%
• Pretax Margin: -148.60%
• Return on Equity: -119.34%
• Return on Assets: -25.83%

Debt

• Debt-to-Equity Ratio: 3.24
• Current Ratio: 1.51
• Quick Ratio: 0.76

Sales & Book Value

• Annual Sales: $7.83 million
• Price / Sales: 3.76
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $0.18 per share
• Price / Book: 40.78

Miscellaneous

• Outstanding Shares: 4,013,000
• Free Float: 30,791,000
• Market Cap: $29.46 million
• Optionable: Not Optionable
• Beta: -0.32